Evidence Supporting Combined Use of Deucrictibant IR with Deucrictibant XR Presented at CIIC Spring 2026 Conference
Go back to Evidence Supporting Combined Use of Deucrictibant IR with Deucrictibant XR Presented at CIIC Spring 2026 Conference| (NASDAQ: PHVS) | Delayed: 30.72 -1.48 (4.6%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.20 | 52 Week High | $ | |||
| Open | $32.33 | 52 Week Low | $ | |||
| Day High | $33.29 | P/E | N/A | |||
| Day Low | $30.60 | EPS | $ | |||
| Volume | 180,201 | |||||

